MALACT

This brand name is authorized in Nigeria.

Active ingredients

The drug MALACT contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemisinin UNII 6A9O50735X - ARTENIMOL
	Artemisinin is used in the treatment of malaria due to species Plasmodium.
	Read more about Artemisinin
2	UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
	Read more about

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100073	Tablet	Malact Tablet TAB 40 mg; 320 mg	186 Dihydroartemisinin 40 mg Piperaquine Phosphate 320 mg A11-100073 Malact Tablet Piperaquine Phosphate, Dihydroartemisinin, Croscarmelose Sodium, Lactose Monohydrate, Pregelatinized Starch, Hypromellose Cps, Magnesium Stearate, Opadry Blue F (Containing Hypromellose, Titanium Dioxide, Peg, Fd&C Blue Indigo Carmine Aluminum Lake, Iron Oxide Yellow) Antimalarial Oral 320 Mg, 40 Mg, 30 Mg, 27 Mg, 22 Mg, 2 Mg, 9 Mg, 16 mg Tablet Prescription Only Medicine (Pom) May And Baker Nigeria Plc May And Baker Nigeria Plc Nigeria 2021-03-30 2026-03-29	30/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF07		P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100073